↓ Skip to main content

Dove Medical Press

Clinical development of neridronate: potential for new applications

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

blogs
1 blog
twitter
4 X users
facebook
2 Facebook pages

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
46 Mendeley
Title
Clinical development of neridronate: potential for new applications
Published in
Therapeutics and Clinical Risk Management, April 2013
DOI 10.2147/tcrm.s35788
Pubmed ID
Authors

Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi, Silvano Adami

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Germany 1 2%
Italy 1 2%
Unknown 43 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 22%
Researcher 7 15%
Student > Doctoral Student 5 11%
Student > Bachelor 5 11%
Student > Ph. D. Student 4 9%
Other 4 9%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 24 52%
Agricultural and Biological Sciences 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Chemistry 2 4%
Earth and Planetary Sciences 1 2%
Other 3 7%
Unknown 12 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2017.
All research outputs
#3,542,654
of 25,374,647 outputs
Outputs from Therapeutics and Clinical Risk Management
#173
of 1,323 outputs
Outputs of similar age
#29,313
of 212,991 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 14 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,991 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.